ORIGINAL RESEARCH
Accepted on 05 Sep 2025
Future Horizons in Diabetes Treatment: Hypoglycemic Activity Of [1,2,4]Triazino[2,3-c]Quinazoline Derivatives
doi 10.3389/fendo.2025.1638013
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Future Horizons in Diabetes: Integrating Gut Microbiota, AI, and Personalized Care
Future Horizons in Diabetes: Integrating Gut Microbiota, AI, and Personalized Care
2,352
Total downloads
11k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
BRIEF RESEARCH REPORT
Accepted on 24 Jul 2025
MICROCIRCULATORY DISTURBANCES IN TYPE 2 DIABETES: EARLY DETECTION USING LASER DOPPLER FLOWMETRY FOR PERSONALIZED CARE
doi 10.3389/fendo.2025.1651525
- 254 views
SYSTEMATIC REVIEW
Published on 09 Jul 2025
Data mining–based analysis to explore the application of an animal model of diabetic gastroparesis
doi 10.3389/fendo.2025.1612473
- 1,074 views
CLINICAL TRIAL
Published on 06 May 2025
Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial
doi 10.3389/fendo.2025.1575087
- 2,351 views
- 1 citation
PERSPECTIVE
Published on 27 Mar 2025
Future horizons in diabetes: integrating AI and personalized care
doi 10.3389/fendo.2025.1583227
- 4,607 views
- 4 citations
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: